EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes

Katharina Marlies Duda, Manuela Gehring, Bettina Wedi iD

European Journal of Immunology · 2025

DOI: 10.1002/eji.70010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Katharina Marlies Duda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Comprehensive Allergy Center, Hereditary Angioedema Center for Rare Diseases, Hannover Medical School, Hannove…. Hauptthemen laut MEDLINE: Receptor, TIE-2, Vascular Endothelial Growth Factor A, Cytokines, Angioedema. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The precise molecular mechanisms underlying angioedema attacks in cases of C1‐inhibitor‐deficient hereditary angioedema (C1‐INH‐HAE), angiotensin‐converting enzyme inhibitor‐induced angioedema (ACEi‐AE), and mast cell‐/histamine‐mediated angioedema (Hist‐AE) are not well understood. These attacks may involve immune and inflammatory mechanisms. We compared serum biomarkers indicating vascular integrity, leakage, angiogenesis, coagulation, and inflammation. During an attack‐free period, we assessed 34 markers simultaneously using multi‐ and/or singleplex ELISA in 25 patients with C1‐INH‐HAE, 17 with ACEi‐AE, 25 with Hist‐AE, and 23 healthy controls. Differential blood counts, C1‐INH‐HAE‐specific laboratory parameters, and recently developed assays addressing early complement and lectin pathways were included. The results revealed significant differences, as well as some similarities. Tie‐2, VEGFs, C1s/C1INHc appear to play a role in all AE types regardless of whether they are bradykinin‐ or histamine‐mediated. Furthermore, evidence was found for a role of IL‐17, eosinophil, and neutrophil chemotactic factors, and the activation of these granulocytes was found. MASP‐1/C1‐INHc indicated early activation of the lectin pathway in ACEi‐AE and HistAE, but not in C1‐INH‐HAE. C1s/C1‐INHc and MASP‐1/C1INHc ratio was able to discriminate C1‐INH‐HAE from controls and the other AE types. Future investigations in C1‐INH‐HAE, ACEi‐AE, and Hist‐AE should not only focus on complement activation but also the interaction with granulocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, TIE-2Vascular Endothelial Growth Factor ACytokinesAngioedemaHumansFemaleMaleMiddle AgedAdultAgedComplement ActivationComplement C1 Inhibitor ProteinBiomarkersChemokines

Stichwörter der Autor:innen

angioedemabiomarkerschemokinesclinical immunologycomplementeosinophilsgranulocyteshereditary angioedemainflammationlectin

Substanzen

Receptor, TIE-2Vascular Endothelial Growth Factor ACytokinesComplement C1 Inhibitor ProteinBiomarkersChemokinesTEK protein, human

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, Comprehensive Allergy Center, Hereditary Angioedema Center for Rare Diseases, Hannover Medical School, Hannover, Germany.

ORCID-Profile: Bettina Wedi

Zitieren

APA

Duda, K. M., Gehring, M., & Wedi, B. (2025). Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes. European Journal of Immunology. https://doi.org/10.1002/eji.70010

Vancouver

Duda KM, Gehring M, Wedi B. Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes. European Journal of Immunology. 2025. doi:10.1002/eji.70010

BibTeX
@article{Duda2025,
  author = {Duda, Katharina Marlies and Gehring, Manuela and Wedi, Bettina},
  title = {Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.70010}
}
Kostenlos starten →